Kushnir, Alexander
Todd, Joshua J.
Witherspoon, Jessica W.
Yuan, Qi
Reiken, Steven
Lin, Harvey
Munce, Ross H.
Wajsberg, Benjamin
Melville, Zephan
Clarke, Oliver B.
Wedderburn-Pugh, Kaylee
Wronska, Anetta
Razaqyar, Muslima S.
Chrismer, Irene C.
Shelton, Monique O.
Mankodi, Ami
Grunseich, Christopher
Tarnopolsky, Mark A.
Tanji, Kurenai
Hirano, Michio
Riazi, Sheila
Kraeva, Natalia
Voermans, Nicol C.
Gruber, Angela
Allen, Carolyn
Meilleur, Katherine G.
Marks, Andrew R.
Funding for this research was provided by:
National Institutes of Health (T32HL120826, UL1TR001873, R01HL145473, R01DK118240, R01HL142903, R01HL061503, R01HL140934, R01AR070194, R25NS076445)
Article History
Received: 9 November 2019
Revised: 14 March 2020
Accepted: 15 March 2020
First Online: 31 March 2020
Compliance with ethical standards
:
: Columbia University and ARM own stock in ARMGO, Inc. a company developing compounds targeting RyR and have patents on Rycals.